PDL-1 and immune checkpoint inhibitors in endometrial cancer #SGOmtg

PDL-1 and immune checkpoint inhibitors in endometrial cancer #SGOmtg

User Photo
sgo2016

4 years
656 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Michael J. Birrer, MD of Massachusetts General Hospital discusses PDL-1 and immune checkpoint inhibitors in endometrial cancer at SGO 2016. Transcription: And the short answer is not a lot and meet your cancer. Has not been one of the first tumors explored for immunotherapy a really was melanoma and real sal. The second wave is involving ovary and. Other tumors in endometrial is probably closer to the third wave. Suffice it to say PT one is expressed. Our and it's likely that PPL one will also be expressed. We have no clue whether that's predictive. For. Response.
Up Next Autoplay
User Photo